NCT05116189 2026-03-09
KEYNOTE-B96
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
Merck Sharp & Dohme LLC
Washington University School of Medicine
Merck Sharp & Dohme LLC
Amgen
Virginia Commonwealth University
University of Missouri-Columbia
G1 Therapeutics, Inc.
British Columbia Cancer Agency
University of Arkansas
University of California, San Diego